Advisory Committee Recommends PMA For Cochlear Implant
This article was originally published in The Gray Sheet
Executive Summary
The Ear, Nose, and Throat panel voted unanimously in favor of Cochlear Ltd.’s Nucleus Hybrid L24 cochlear implant at its Nov. 8 meeting. The company’s PMA application is based on a 50-patient single-arm trial.